Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.60 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18428870 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL17187415 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL17187416 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL17187504 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL17187465 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL17187505 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL9543418 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL17187473 | 1.00 | EPHX1 (0.60) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL19286042 | 0.98 | EPHX1 (0.59) | EPHX1EPHX2SIGMAR1MEN1KMT2A | |
| SCHEMBL16661526 | 0.98 | EPHX1 (0.59) | EPHX1EPHX2SIGMAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115368824-A | Fast curing migration-free compositions based on organic polymers containing silane groups | SIKA技术股份公司 | 2022-11-22 | — | — | CN | disclosed |
| EP-3131994-B1 | FAST CURING MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS | SIKA TECH AG (CH) | 2021-06-09 | — | — | EP | disclosed |
| US-10100069-B2 | Rapid-curing, migration-free composition based on organic polymers containing silane groups | SIKA TECHNOLOGY AG (CH) | 2018-10-16 | — | — | US | disclosed |
| EP-3131994-A1 | RAPID-CURING, MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS | Sika Technology AG (CH) | 2017-02-22 | — | — | EP | disclosed |
| CN-106459668-A | Fast curing migration-free compositions based on organic polymers containing silane groups | SIKA技术股份公司 | 2017-02-22 | — | — | CN | disclosed |
| US-20170037191-A1 | RAPID-CURING, MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS | SIKA TECHNOLOGY AG (CH) | 2017-02-09 | — | — | US | disclosed |
| WO-2015158863-A1 | RAPID-CURING, MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS | SIKA TECHNOLOGY AG (CH) | 2015-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037191-A1 | RAPID-CURING, MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS | CDH1, ITGA1, ICAM1 | EPHX1 978/4885EPHX2 1528/4885SIGMAR1 583/4885 |
| US-10100069-B2 | Rapid-curing, migration-free composition based on organic polymers containing silane groups | CDH1, PIEZO1, ICAM1 | EPHX1 1324/4885EPHX2 1645/4885SIGMAR1 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.